Legal News

European Approval Granted for Novartis’s Meningitis B Vaccine
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

Approval has been granted to Novartis for the very first vaccine that would fight meningitis B, according to Reuters. Now, the company is looking to convince countries struggling with cash to add it to their routine vaccination programs so that the drug can become a success commercially.

“Novartis is working with health authorities to provide access to Bexsero as soon as possible,” the company said on Tuesday.

  
What
Where


As of right now, there is no vaccine that offers broad protection against meningitis B, which is caused by bacteria that causes inflammation of brain lining and the spinal cord. Meningitis B can cause someone to die within 24 hours.

“We don’t expect a rapid ramp-up for Bexsero, since Novartis will need the support of each single E.U. member state to obtain inclusion into the national immunization program and the reimbursement scheme,” Kepler Capital Markets analyst Fabian Wenner said.

The market in Europe for Bexsero is expected to range from $600 to $700 million, which is much lower than Novartis’s best-selling drug, Diovan. Diovan posted sales of $5.7 billion back in 2011. The drug is for blood pressure.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




“Diovan monotherapy is yet to see generic and multiple generic competition in the U.S., while consensus estimates for the new respiratory franchise are likely too high,” Wenner said.

According to medical data, close to 10 percent of people who contract meningitis B die even if they receive appropriate treatment. Close to 20 percent of the survivors suffer disabilities ranging from brain damage to hearing impairment.





 

RELEVANT JOBS

Senior M&A Attorney

USA-IL-Chicago

Our corporate boutique law firm is seeking a senior level M&A attorney with a book of business that ...

Apply now

Paralegal / Legal Assistant

USA-MN-Rochester

O\'Brien & Wolf, L.L.P., a general practice law firm in Rochester, Minnesota, is seeking a Family La...

Apply now

Medical Malpractice Attorney

USA-CO-Denver

Hall & Evans, LLC, one of Denver\'s most recognized and respected law firms, is continuing its expan...

Apply now

Litigation Associate Attorney

USA-CO-Denver

Hall & Evans, L.L.C., one of Colorado\'s most established law firms, currently has an opportunity fo...

Apply now

BCG FEATURED JOB

Locations:

Keyword:



Search Now

Senior Real Estate Partner-level Attorney

USA-NY-New York City

New York City office of a BCG Attorney Search top ranked law firm seeks Senior Real Estate Partner-l...

Apply Now

Senior Staff Products Liability and Mass Torts Attorney

USA-CA-Los Angeles

Los Angeles office of our client seeks Senior Staff Products Liability and Mass Torts Attorney with ...

Apply Now

Partner-level Products Liability, Consumer Class Actions Attorney

USA-CA-Los Angeles

Los Angeles office of our client seeks Partner-level Products Liability, Consumer Class Actions Atto...

Apply Now

Most Popular

SEARCH IN ARCHIVE

To Top